This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Porcine Cyclin-Dependent Kinase 4 (CDK4) Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for porcine cyclin-dependent kinase 4. It can be applied to WB assay of porcine cyclin-dependent kinase 4.
Specifications
Target Information
Cyclin-dependent kinase 4 (CDK4) is a key cell cycle regulator that, in complex with cyclin D, phosphorylates the retinoblastoma tumor suppressor protein (pRb), leading to the release of E2F transcription factors. This action allows the cell to move from the G1 phase into the S phase, where DNA replication occurs. The activity of CDK4 is tightly controlled by the cell's internal checkpoints, which ensure that the cell is ready to proceed through the cycle. Dysregulation of CDK4 activity has been implicated in various cancers due to its role in cell cycle progression. Overexpression of CDK4 or loss of function in the INK4 family of cyclin-dependent kinase inhibitors can result in uncontrolled cell proliferation.
Shipping and Storage
This product is shipped with ice gel packs. Store at -20°C (up to 12 months) on receipt. Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Ikuta, Mari, et al. "Crystallographic approach to identification of cyclin-dependent kinase 4 (CDK4)-specific inhibitors by using CDK4 mimic CDK2 protein." Journal of Biological Chemistry 276.29 (2001): 27548-27554.